FDA extends Entereg review period
February 11 2008
The FDA will extend by three months the review time of GlaxoSmithKline and Adolor's jointly- developed post-operative ileus treatment Entereg.
Your Email Address: *
Recipient(s) Email Address: *
(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)
The e-mail address(es) that you supply to use this service will only be used to send the requested article.